25 February 2026Possible offerHealthcare
EQT has agreed to acquire Oxford Biomedica plc, a UK-based CDMO and viral vector specialist, in a transaction announced on 25 February 2026. The specific financial terms…
- Buyer
- EQT
- Target
- Oxford Biomedica plc
- Deal value
- Not disclosed
- Deal type
- unknown
24 February 2026CompletedHealthcare
Wood Violet Fertility LLC and Family Beginnings P.C. entered the Exit Mode archive.
- Buyer
- Wood Violet Fertility LLC
- Target
- Family Beginnings P.C.
- Deal value
- USD 400,000
- Deal type
- strategic acquisition
23 February 2026Firm intentionHealthcare
Shorepower Technologies, Inc. and Aeternum Health LLC entered the Exit Mode archive.
- Buyer
- Shorepower Technologies, Inc.
- Target
- Aeternum Health LLC
- Deal value
- USD 1,500,000
- Deal type
- strategic acquisition
19 February 2026In reviewHealthcare
GTCR has agreed to acquire ZENTIVA in a transaction announced on 19 February 2026. The deal involves the pharmaceutical sector, classified under NaceV2Sector_C_21. No fi…
- Buyer
- GTCR
- Target
- ZENTIVA
- Deal value
- Not disclosed
- Deal type
- unknown
17 February 2026CompletedHealthcare
Apimeds Pharmaceuticals US, Inc. and MindWave entered the Exit Mode archive.
- Buyer
- Apimeds Pharmaceuticals US, Inc.
- Target
- MindWave
- Deal value
- Not disclosed
- Deal type
- merger of equals
16 February 2026CompletedHealthcare
Medpal AI plc has agreed to acquire Universal Pharmacy Ltd in a strategic acquisition valued at £45,000. The transaction was settled entirely in cash and relates to the…
- Buyer
- Medpal AI plc
- Target
- Universal Pharmacy Ltd
- Deal value
- GBP 45,000
- Deal type
- strategic acquisition
15 February 2026In reviewHealthcare
THERMO FISHER and CLARIO entered the Exit Mode archive.
- Buyer
- THERMO FISHER
- Target
- CLARIO
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
3 February 2026CompletedHealthcare
Erigen and Tempest Therapeutics, Inc. entered the Exit Mode archive.
- Buyer
- Erigen
- Target
- Tempest Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
26 January 2026In reviewHospitality & Leisure
LOV GROUP has agreed to acquire TIPICO in a transaction announced on 26 January 2026. The deal involves the sports betting and gaming sector, classified under NaceV2Sect…
- Buyer
- LOV GROUP
- Target
- TIPICO
- Deal value
- Not disclosed
- Deal type
- unknown
23 January 2026CompletedHealthcare
BioCryst Pharmaceuticals, Inc. and Astria Therapeutics, Inc. entered the Exit Mode archive.
- Buyer
- BioCryst Pharmaceuticals, Inc.
- Target
- Astria Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
22 January 2026In reviewHealthcare
BLACKSTONE / TPG and HOLOGIC entered the Exit Mode archive.
- Buyer
- BLACKSTONE / TPG
- Target
- HOLOGIC
- Deal value
- Not disclosed
- Deal type
- pe acquisition
21 January 2026CompletedHealthcare
Smith+Nephew has agreed to acquire Integrity Orthopaedics in a strategic acquisition within the Medical Technology sector. The transaction, valued at USD 225 million, in…
- Buyer
- Smith+Nephew
- Target
- Integrity Orthopaedics
- Deal value
- USD 225,000,000
- Deal type
- strategic acquisition
19 January 2026CompletedHealthcare
GlaxoSmithKline LLC and RAPT Therapeutics, Inc. entered the Exit Mode archive.
- Buyer
- GlaxoSmithKline LLC
- Target
- RAPT Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
16 January 2026CompletedHospitality & Leisure
TriArtisan Capital Advisors (with Yadav Enterprises and Treville Capital) and Denny's, Inc. entered the Exit Mode archive.
- Buyer
- TriArtisan Capital Advisors (with Yadav Enterprises and Treville Capital)
- Target
- Denny's, Inc.
- Deal value
- USD 145,500,000
- Deal type
- going private
16 January 2026Scheme proposedHospitality & Leisure
Jardine Strategic Limited has agreed to acquire Mandarin Oriental International Limited in a strategic acquisition. The target is incorporated in Bermuda and the transac…
- Buyer
- Jardine Strategic Limited
- Target
- Mandarin Oriental International Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
7 January 2026CompletedHealthcare
Merck Sharp & Dohme LLC and Cidara Therapeutics, Inc. entered the Exit Mode archive.
- Buyer
- Merck Sharp & Dohme LLC
- Target
- Cidara Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
2 January 2026CompletedHealthcare
Sunstring Ltd has agreed to acquire the assets of A.M.S 2000 Trading Impex SRL, a diagnostics distributor based in Israel, in a transaction structured as an asset sale.…
- Buyer
- Sunstring Ltd
- Target
- A.M.S 2000 Trading Impex SRL
- Deal value
- Not disclosed
- Deal type
- asset sale
23 December 2025CompletedHealthcare
YA II PN, LTD and JUPITER NEUROSCIENCES, INC. entered the Exit Mode archive.
- Buyer
- YA II PN, LTD
- Target
- JUPITER NEUROSCIENCES, INC.
- Deal value
- USD 1,860,000
- Deal type
- minority stake
17 December 2025In reviewHospitality & Leisure
Apollo Funds has agreed to acquire Club Atletico de Madrid in a transaction valued at an undisclosed sum. The deal involves the purchase of a Spanish sports activities a…
- Buyer
- APOLLO FUNDS
- Target
- CLUB ATLETICO DE MADRID
- Deal value
- Not disclosed
- Deal type
- unknown
15 December 2025CompletedHealthcare
AI Technology Group Inc. and AVM Biotechnology Inc. entered the Exit Mode archive.
- Buyer
- AI Technology Group Inc.
- Target
- AVM Biotechnology Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
15 December 2025CompletedHealthcare
XOMA Royalty Corporation and Generation Bio Co. entered the Exit Mode archive.
- Buyer
- XOMA Royalty Corporation
- Target
- Generation Bio Co.
- Deal value
- Not disclosed
- Deal type
- going private
21 November 2025CompletedHealthcare
Lixte Biotechnology Holdings, Inc. and Liora Technologies Europe Ltd. entered the Exit Mode archive.
- Buyer
- Lixte Biotechnology Holdings, Inc.
- Target
- Liora Technologies Europe Ltd.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
12 November 2025In reviewHealthcare
WARBURG PINCUS has agreed to acquire SEBIA in a transaction announced on 12 November 2025. The deal involves a company operating across multiple industrial sectors, incl…
- Buyer
- WARBURG PINCUS
- Target
- SEBIA
- Deal value
- Not disclosed
- Deal type
- unknown
11 November 2025In reviewHealthcare
CAPVEST has agreed to acquire STADA GROUP in a transaction announced on 11 November 2025. The deal involves a company operating within the pharmaceutical manufacturing s…
- Buyer
- CAPVEST
- Target
- STADA GROUP
- Deal value
- Not disclosed
- Deal type
- unknown
3 November 2025CompletedHealthcare
QOL Medical, LLC and Evoke Pharma, Inc. entered the Exit Mode archive.
- Buyer
- QOL Medical, LLC
- Target
- Evoke Pharma, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
30 October 2025In reviewHealthcare
RHÔNE CAPITAL has agreed to acquire Invacare in a transaction announced on 30 October 2025. The deal concerns a business operating within the NaceV2Sector_C_32.50 classi…
- Buyer
- RHÔNE CAPITAL
- Target
- INVACARE
- Deal value
- Not disclosed
- Deal type
- unknown
29 October 2025In reviewHealthcare
WATERS has agreed to acquire the BIOSCIENCES AND DIAGNOSTIC SOLUTIONS BUSINESSES of BD in a strategic acquisition announced on 29 October 2025. The transaction involves…
- Buyer
- WATERS
- Target
- BD (BIOSCIENCES AND DIAGNOSTIC SOLUTIONS BUSINESSES)
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
22 October 2025CompletedHealthcare
Alkermes plc and Avadel Pharmaceuticals plc entered the Exit Mode archive.
- Buyer
- Alkermes plc
- Target
- Avadel Pharmaceuticals plc
- Deal value
- USD 21
- Deal type
- strategic acquisition
21 October 2025CompletedHealthcare
Hopper Parent Inc. and Hologic, Inc. entered the Exit Mode archive.
- Buyer
- Hopper Parent Inc.
- Target
- Hologic, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
21 October 2025CompletedHealthcare
Machinify (New Mountain Capital) and Performant Healthcare Inc entered the Exit Mode archive.
- Buyer
- Machinify (New Mountain Capital)
- Target
- Performant Healthcare Inc
- Deal value
- USD 7.75
- Deal type
- going private